Beneficient (NASDAQ:BENF – Get Free Report) released its earnings results on Friday, August 14th. The company reported ($0.47) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($2.06) by $1.59, FiscalAI reports. The business had revenue of $15.93 million during the quarter, compared to analysts’ expectations of $10.16 million.
Beneficient Stock Down 23.2%
BENF stock opened at $0.63 on Friday. The company has a 50 day moving average of $2.49 and a two-hundred day moving average of $3.17. The company has a market cap of $9.13 million, a price-to-earnings ratio of -0.09 and a beta of -0.04. Beneficient has a 12-month low of $0.57 and a 12-month high of $12.48.
Wall Street Analyst Weigh In
Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of Beneficient in a research report on Wednesday, June 24th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock currently has an average rating of “Sell”.
Beneficient Company Profile
Beneficient, a technology-enabled financial services company, provides liquidity solutions and related trustee, custody and trust administrative services to participants in the alternative asset industry in the United States. It operates through Ben Liquidity, Ben Custody, and Customer ExAlt Trusts segments. The company offers Ben AltAccess platform for secure, online, and end-to-end delivery of each of the Ben business unit products and services, including upload documents, and work through tasks, and complete their transactions with standardized transaction agreements.
Recommended Stories
- Five stocks we like better than Beneficient
- Laser Focus: 2 Optical Stocks Lighting Up AI
- Aeluma’s Selloff Could Be Setting Up Its Next Big Move
- Crypto Bill Stalls, Smart Money Calls: Time to Buy the Dip?
- The September Scramble: Find Sanctuary in These 3 Defensive Dividend Stocks
Receive News & Ratings for Beneficient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Beneficient and related companies with MarketBeat.com's FREE daily email newsletter.
